Abstract
Telomerase reverse transcriptase (TERT) promoter mutations have been found to increase telomerase activity and thereby drive oncogenic processes. TERT mutations have been identified in many types of malignancies and are frequently found in anaplastic, follicular, and papillary thyroid cancer. Genetic testing has become an important tool in evaluating thyroid lesions especially with indeterminant fine needle biopsy results. Studies have shown TERT promoter mutations to be associated with poor prognosis and are only very rarely found in benign thyroid lesions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
